cells, inflamed GKO mice developed aggressive gastric tumors. Tumor development was not observed in mouse stomachs transplanted with wtMSC or stMSC ShhKO cells. Compared with stMSC ShhKOtransplanted mice, within the inflamed GKO mouse stomach, Shhexpressing stMSC vect -and wtMSC Shh -induced proliferation of CD44-positive cells. CD44-positive cells clustered in gland-like structures within the tumor stroma and were positive for Patched (Ptch) expression. We conclude that Shh, secreted from MSCs, provides a proliferative stimulus for the gastric epithelium that is associated with tumor development, a response that is sustained by chronic inflammation.
inflammation; cancer stem cells; Sonic Hedgehog; CD44 BONE MARROW-DERIVED MESENCHYMAL STEM CELLS (BM-MSCs) are known to sustain cancer cells by creating a microenvironment favorable for tumor growth and immunosuppression of the host immune response (13) . Normally BM-MSCs do not exhibit malignant properties, but with long-term culture BMMSCs "spontaneously transform" (stMSCs), can be propagated in vitro for extended periods, and develop a cancer-promoting phenotype (18) . In vivo, in the inflamed mammary tissue and also in response to chronic gastritis BM-MSCs undergo mutations and acquire a cancer-promoting phenotype (9, 10, 13, 25) . Bone marrow-derived cells, in particular cancer-associated fibroblasts generated from MSCs, are recruited to the gastric epithelium in response to chronic gastritis (14, 25) . In vivo recruitment of bone marrow-derived cells occurs over several months with chronic inflammation (14, 25) . In addition, the mechanism by which these cells contribute to tumor development is unclear. Therefore, the current study uses transplantation of an in vitro malignantly transformed mesenchymal stem cell line (stMSC) to accelerate cancer progression in a murine model that in vivo would occur over the course of 1 yr with chronic inflammation.
With recruitment to the gastric mucosa, BM-MSCs may sustain cancer cells by creating a microenvironment favorable for tumor growth and suppression of the host immune response (10, 13, 25) . Our laboratory has demonstrated that gastritis promotes the in vivo activation of BM-MSCs to a phenotype reminiscent of a cancer-promoting cell (9, 10) . In particular, this cancer-promoting phenotype is characterized by an IFN␥ and transforming growth factor-␤ (TGF-␤)-dependent induction of increased levels of MSC-derived Sonic Hedgehog (Shh) expression (9) . There is a well-established role for liganddependent Shh signaling in the development of cancer in a number of tissues (3, 33) . Earlier studies demonstrated that growth of epithelial digestive tract tumors that included esophagus, biliary tract, pancreas, and stomach is regulated by endogenous expression of Hedgehog (Hh) ligands such as Shh in an autocrine-juxtacrine manner (3) . Since then, Yauch et al. (33) have shown that Hh ligands fail to activate signaling in tumor epithelial cells but rather promote signaling in the tumor stroma. The source and target of Shh ligand in the stomach during gastric cancer development are not well defined. The presence of MSCs in the tumor stroma could facilitate tumorigenesis via the secretion of a number of cancer promoting factors including Shh.
Biomarkers are comprised of cluster-of-differentiation (CD) genes and in particular CD44, a cell surface receptor for hyaluronate (1) , is a known ␤-catenin target gene and is a cell surface adhesion molecule expressed on a variety of cells including gastric epithelial cells. Notably, CD44 has been identified as a gastric cancer stem cell marker and is expressed by resident tissue stem cells along the gastrointestinal tract (16, 27, 30) . Typically, BM-MSCs physiologically lack expression of CD44 and acquire CD44 expression only after in vitro culture (24) . However, in vivo within the tumor microenviron-ment, it is also possible that CD44 expression contributes to the differentiation of MSCs into an activated fibroblast phenotype (26) . Thus it is unknown whether increased CD44 expression associated with gastric tumors is attributed directly to engraftment of recruited MSCs or the expansion of a resident epithelial stem cell population.
We hypothesize that cancer-promoting BM-MSCs promote the aberrant proliferation of the epithelium via induction of the Shh signaling pathway. To test this hypothesis, the current study uses the gastric submucosal transplantation of in vitro malignantly transformed stMSCs and wild-type (wt)MSCs, which overexpress Shh ligand, to accelerate cancer progression in a murine model. The current studies demonstrate that Shh, derived from MSCs, provides a proliferative stimulus for the gastric epithelium, a response that is sustained by chronic inflammation.
MATERIALS AND METHODS
Animals. C57BL/6 (strain no. 000664, BL/6) and IRG (insulator/ red/green, strain no. 008705) mice were purchased from Jackson Laboratories (Bar Harbor, ME). Gastrin-deficient (GKO) mice backcrossed onto a C57BL/6 background were the gift of Dr. Linda Samuelson (University of Michigan) (12) . All mouse studies were approved by the University of Cincinnati Institutional Animal Care and Use Committee that maintains an American Association of Assessment and Accreditation of Laboratory Animal Care Facility.
BM-MSC culture. stMSCs used were isolated as previously described and transfected with a pDsRed-Hyg-C1 plasmid expressing red fluorescent protein (RFP) before being maintained in culture for 12 mo (17) . wtMSCs were isolated by flushing 6-to 8-wk-old IRG femur and tibia and subsequent culture and passage of the adherent cell population. All cells were cultured using HyClone DMEM culture media supplemented with 15% fetal calf serum and 1% penicillinstreptomycin under normal conditions.
Shh knockdown by lentivirus-mediated short hairpin RNA using stMSCs. Five MISSION lentiviral transduction particle clones containing different sequences of short hairpin RNA (shRNA) for Shh and a pLKO.1-puro component conferring puromycin resistance were used to transduce the RFP-tagged stMSCs according to the provided protocol (Sigma-Aldrich). Briefly, RFP-labeled stMSCs were incubated with lentiviral particles with ExpressMag magnetic beads (SigmaAldrich) on a magnet (Oz Biosciences Super Magnetic Plate, MF10000) for 15 min. Cells were removed from the magnet and incubated for a further 16 h after which time media were changed and replaced with puromycin selection culture media (DMEM culture media containing 10% fetal calf serum, 1% penicillin/streptomycin, and 10 g/ml puromycin) for 7-10 days. The effective puromycin dose needed to eliminate nontransduced cells was determined previously through a puromycin kill curve that tested concentrations from 0 to 50 g/ml (data not shown). The lowest concentration that killed all nontransduced cells at 3-4 days post treatment was established as 10 g/ml. Transduced cells were denoted by a unique clone ID number with cell lines transduced with shRNA for Shh (stMSC ShhKO ) numbered 59 -63. A pLKO.1-puro vector transduced RFP-MSC cell line (stMSC vect ) served as the control for the endogenous level of Shh gene expression. Immunoprecipitation and Western blot analysis were used to confirm Shh knockdown and RFP expression.
Transfection of MSCs to overexpress Shh. The plasmid (Origene CW101340) was combined with the Origene Turbofectin reagent at ratios of 0:1, 1:1, 2:1, 3:1, and 4:1 and incubated for 15 min at room temperature (RT). The transfection reagent was then added drop-wise to wtMSCs at 70% confluence and allowed to incubate for 24 h before cells were put under selection in normal media with puromycin. The effective puromycin dose needed to eliminate nontransfected cells was determined previously through a puromycin kill curve testing concentrations from 0 to 10 g/ml (data not shown). The lowest concentration that killed all nontransfected cells at 3-4 days post treatment was established as 2 g/ml.
Flow cytometry. The Mouse Multipotent Mesenchymal Stromal Cell Marker Antibody Panel was used to label all MSC cell lines for Sca-1, CD106, CD105, CD73, CD29, and CD44 and the hematopoietic markers CD45 and CD11b (R&D Systems, SC018). Cells were suspended at a concentration of 1 ϫ 10 6 cells/ml and 90 l transferred to eppendorf tubes for staining. Cells were incubated with 10 l of primary antibody for 30 min at 4°C, washed, and then incubated with a 1:100 dilution of Alexa Fluor anti-rat 488 for 30 min at 4°C. Cells were washed, suspended in fixation media (Invitrogen GAS001S5) for 15 min at RT, and then washed and resuspended in 5% BSA/PBS for analysis. To measure proliferation, the cells were stained with propidium iodide for 45 min for measurement of DNA content using the FACSCalibur system (Becton Dickinson). The measured values of peak fluorescence per total number of cells were obtained using the program CellQuest Pro (Becton Dickson). The percentage of cells from the population in each phase of the cell cycle was calculated from the peak fluorescence measurements through analysis with ModFit LT software. All analyses were performed on a BD FACSCalibur flow cytometer and analyzed using FlowJo Software, Version 9.
Gastric wall injection of bone marrow and stMSCs. Injection of MSCs into the serosa of the gastric wall in C57BL/6 and GKO mice was performed according to a previously established protocol (22) . Briefly, mice were anesthetized and prepared aseptically before the stomach was exteriorized. Cultured wtMSC, wtMSC Shh , stMSC vect , or stMSC ShhKO cells were trypsinized at 70 -80% confluence and washed, and 2 ϫ 10 6 cells were resuspended in 1 ml of sterile PBS. With the use of BD U-100 insulin syringes, 10-l volumes of the cell suspension were injected at five locations along the greater curvature of the gastric wall, with sites within both the fundus and antrum of the stomach. The stomach was placed back inside the abdominal cavity, and the abdominal muscle layer and cutaneous layers were sutured using 4 -0 Ethicon Vicryl sutures. Mice were injected with 200 l of bromodeoxyuridine (BrdU) labeling reagent at least 24 h before euthanasia at 30 and 60 days postsurgery.
Epithelial-mesenchymal separation of gastric tissue. A gastric biopsy was collected from each experimental group after the stomach was removed, opened along the greater curvature, and rinsed in PBS with forestomach discarded. Biopsies were collected in 10 ml HBSS without Ca 2ϩ Mg 2ϩ on ice and then transferred to 10 ml of 10 mM EDTA/HBSS, without Ca 2ϩ and Mg 2ϩ for 3 min at RT. After being washed with HBSS without Ca 2ϩ and Mg 2ϩ , the biopsies were placed at 37°C in 10 ml of 1 mg/ml dispase/HBSS without Ca 2ϩ and Mg 2ϩ with agitation for 30 min. Mesenchymal and epithelial layers were separated manually using forceps and a dissecting scope. Tissue was harvested and homogenized in either Trizol or protein lysis buffer with protease inhibitor before further analysis.
Laser capture microdissection using paraffin-embedded gastric tissue. Eight micron paraffin-embedded sections were stained using the ARCTURUS Paradise PLUS FFPE Laser Capture Microdissection (LCM) Staining Kit (Life Technologies) and dehydrated (30-s ethanol submersions followed by a 5-min submersion in xylene and a 5-min drying period) according to the manufacturer's protocol. Cells specific to each region were isolated using the Molecuar Devices/ Arcturus VERITAS LCM System (model 704). The ultraviolet cutting laser was used to ablate the cells within the morpholgically distinct gland-like structures within the tumor stroma. These areas are representative of those staining positive for CD44 by immunofluorescence. An infrared laser power of 80 mW and pulse of 2,500 ms was then used to capture the cells. RNA was extracted using the Arcturus Paradise Plus RNA Extraction and Isolation Kit (Life Technologies) and analyzed by quantitative (q)RT-PCR.
RNA isolation and qRT-PCR. Total RNA was isolated from cells or stomach tissue using Trizol reagent according to the manufacturers protocol (TriReagent; Molecular Research Center). For qRT-PCR using Taqman Reagents and the Applied Biosystems StepOne Real Time PCR System, the High Capacity cDNA Reverse Transcription Kit (Applied Biosystems) was used for cDNA synthesis following the recommended protocol. Analysis of Shh Pathway component expression was performed using the following TaqMan Gene Expression Assays according to the recommended protocol: Shh, 00436528_m1; Patched (Ptch), Mm00970977_m1; Gli1, Mm00494645_m1; Gli2, Mm01293111_m1; Gli3, Mm00492345_m1; Hedgehog interacting protein (Hhip), Mm00469580_m1; and hypoxanthine guanine phosphoribosyl transferase (HPRT), Mm00446968_m1. Fold change of gene expression was determined relative to wtMSCs for all cell lines using the method of Livak and Schmittgen (19a) . For qRT-PCR of epithelial and mesenchymal gastric layers, RNA was reverse transcribed using the High Capacity cDNA Reverse Transcription Kit according to the manufacturer's protocol. Analysis of epithelium and mesenchyme was then performed using the following TaqMan Gene Expression Assays according to the recommended protocol: vimentin, Mm01333430_m1; Actg2a, Mm00725412_s1; and cytokeratin 20, Mm00508106_m1. All samples were run on a 1.5% agarose gel and bands visualized and quantified using the Bio-Rad Quantity One 1-D Analysis Software.
Western blot analysis. Epithelial or mesenchymal gastric samples were loaded onto 4 -20% Tris-Glycine Gradient Gels (Invitrogen) and run at 80 V, 3.5 h before transfer to nitrocellulose membranes (Whatman Protran, 0.45 M) at 105 V, 1.5 h. Membranes were blocked for 1 h at RT using prepared KPL Detector Block Solution (Kirkegaard & Perry Laboratories). Membranes were incubated overnight at 4°C with a 1:200 dilution of Shh antibody (N-19, sc-1194; Santa Cruz Biotechnology) followed by a 1-h incubation with a 1:1000 dilution Alexa Fluor anti-goat 680 (Invitrogen). An antibody against GAPDH (Millipore, MAB374) and Alexa Fluor anti-mouse 680 were used at 1:1,000 for 1 h at RT. Blots were imaged using a scanning densitometer along with analysis software (Odyssey Infrared Imaging Software System).
Immunohistochemical and immunofluorescent staining. Stomach sections spanning both the fundic and antral regions collected from experimental mice were fixed for 16 h in either 4% paraformaldehyde or Carnoy's Fixative (for BrdU-labeled samples), paraffin embedded, and sectioned at 5 M with H&E staining. Prepared slides were deparaffinized with antigen retrieval performed by submerging in boiling solution (1:100 dilution, Antigen Unmasking Solution in dH 2O; Vector Laboratories H-3300) for 10 min followed by 20 min at RT. For immunohistochemistry, endogenous peroxidase activity was blocked by incubating slides in 3% hydrogen peroxide/ethanol for an additional 30 min. Sections were then blocked with 5% BSA/PBS (for BrdU-labeled samples) or 20% normal serum for 20 min, RT. BrdU color development was performed according to manufacturer's protocol (Roche cat. no. 11 296 736 001).
The following primary antibodies were used: anti-BrdU (1:20, 30 min, 37°C; Roche cat. no. 11 296 736 001), anti-CD44 (1:100, 1 h, RT; Abcam ab25340), anti-CD44v6 (1:100, 16 h, RT; AbD Serotec MCA1967), anti-Patched G-19 (1:200, 16 h, 4°C; Santa Cruz sc-6149), and anti-mouse Ki67 (prediluted Ki67 from Ventana Medical Systems, Tucson, AZ, catalog no. 790 -4286). Secondary antibodies were anti-mouse IgG (1:20, 30 min, 37°C; Roche cat. no. 11 296 736 001), biotin-conjugated rabbit anti-goat according to the manufacturer's protocol (VECTASTAIN Elite ABC Kit; Vector Laboratories), or Alexa Fluors at 1:100 for 1 h at RT (Invitrogen). For immunohistochemistry, sections were first incubated in ABC Reagent then DAB substrate for 5 min at RT (Vector Laboratories SK-4100). Immunohistochemical slides were dehydrated and mounted using Permount and images viewed and captured under light microscopy (Olympus BX60 with Diagnostic Instruments "Spot" Camera). Immunofluorescent slides were mounted using Vectashield HardSet Mounting Medium (Vectors Laboratories H-1400). Images were captured using a Zeiss LSM510 META confocal microscope.
In situ hybridization for the Y chromosome. In situ hybridization for the Y chromosome was performed using a digoxigenin-labeled Y chromosome probe (Empire Genomics Buffalo, NY) on the Discovery XT machine (Ventana Medical Systems) using manufacturer's instructions. Briefly, deparaffinized sections were pretreated with proteinase and incubated with the digoxigenin-labeled Y chromosome probe at 37°C for 4 h in RiboHyb solution. After the incubation, slide were washed in SSC using manufacturer's recommendations. The slides were then incubated with Anti-DIG rabbit antibody (Sigma) for 12 min with detection using iVIEW Blue Plus Detection Kit (Ventana Medical Systems). Images were captured using an Olympus BX60 with Diagnostic Instruments "Spot" Camera.
Histology and histological scoring. All tissue processing and staining were performed by McClinchey Histology Laboratories (Stockbridge, MI). Histological score was graded on parietal cell loss (atrophy), foveolar hyperplasia, and neutrophil and lymphocytic infiltration as previously performed (31) . A score of 1, 2, 3, or 4 corresponds to 25, 26 -50, 51-75, or 76 -100% of the total mucosa affected, respectively.
Luminex-based multiplex assay. Tissue was homogenized in PBS saline supplemented with protease inhibitor (Roche) and centrifuged for 30 min at 13,000 rpm at 4°C. Cytokine concentrations (IFN␥, IL-1␤, TGF-␤, and IL-6) in the tissue sample supernatants were determined by ELISA using Milliplex Multiplex kits (Millipore, Billerica, MA) according to manufacturer's protocol. Briefly, in a 96-well multiscreen filter plate, 25-l sample in duplicate was incubated with 25 l antibody-coated beads overnight at 4°C on a plate shaker. Plates were then washed two times on a vacuum apparatus and 25 l of secondary antibody were added and incubated at RT for 1 h, shaking. Finally, 25 l of streptavidin-RPE were added directly to the secondary antibody and incubated for 30 min at RT with shaking. Plates were then washed two more times, and 100 l of sheath fluid were added. Plates were shaken for 5 min and then read using luminex technology on the Bio-Plex (Bio-Rad, Hercules, CA). Concentrations were calculated from standard curves using recombinant proteins and expressed in picograms per milliliters. The cytokine analysis was conducted by the Cytokine and Mediator Measurement Core Laboratory run by Dr. Marsha Wills-Karp (Cincinnati Children's Digestive Health Center).
Statistical analysis. Results were analyzed by unpaired t-test or two-way ANOVA as appropriate using commercially available software (GraphPad Prism; GraphPad Software, San Diego, CA). A P value Ͻ0.05 was considered significant.
RESULTS

Loss of Shh within the gastric mucosa of GKO mice by 4 mo of age correlates with severe gastritis, parietal cell atrophy, and elevated inflammatory cytokines.
Mice that lack the gastrin gene (gastrin-deficient mice, GKO) develop severe inflammation and mucous gland metaplasia due to hypochlorhydria or loss of gastric acidity (38) . As a consequence of the hypochlorhydria, bacterial overgrowth develops and initiates chronic gastritis (38) . The subsequent morphological changes in the GKO gastric mucosa from the initiation of this inflammatory response to tumor development mimic Helicobacter pyloriinfected human mucosa (5, 35, 38) . Shh expression and processing occurs via a mechanism that is dependent on acid secretion (36, 37) . Because GKO mice are hypochlorhydric from birth (12), it is not surprising that Shh expression and processing is lost in the stomach of these animals (36) . This made the GKO model ideal for the study of the role of Shh derived from exogenous or recruited cell types in gastric pathology.
To quantify the expression of Shh within the stomachs of control (BL/6) and GKO mice, we used an enzymatic dissociation to separate the epithelium from the mesenchymal (nonepithelium) tissue. Purity of the epithelium and mesenchymal compartments were assessed based on the expression of mesenchymal (vimentin, Actg2a) and epithelial (cytokeratin 20, keratin) markers (Fig. 1A) . Consistent with published findings, we observed a significant loss of Shh within the epithelium of the GKO mouse stomachs compared with the noninflamed BL/6 controls and undetectable levels of Shh expression within the mesenchymal compartment in both experimental groups (Fig. 1, B and C) . Histological evaluation revealed significant atrophic gastritis within the stomachs of GKO (Fig. 1E ) mice compared with BL/6 (Fig. 1D) control animals by 4 mo of age, coincident with the loss in Shh gene expression (Fig. 1C) . Quantification of cytokine expression by Luminex-based multiplex assay revealed significantly elevated IL-1␤, TGF-␤, IL-6, and IFN␥ concentrations within the stomach tissues collected from GKO mice compared with the BL/6 group (Fig.  1F) . Collectively, these findings demonstrate that GKO mice exhibit significant gastric inflammation that is accompanied by the loss of Shh within the epithelium.
Overexpression and silencing of Shh within BM-MSCs. To study the effect of MSC-derived Hh signaling on the gastric epithelium, several MSC cell lines were established. As a model of malignant MSCs, an in vitro spontaneously transformed MSC cell line (stMSC) was used that express elevated levels of Shh as shown by immunoblot ( Fig. 2A) (13, 17) . A pLKO.1-puro base lentiviral vector expressing a short hairpin sequence against the transcript of the Shh gene was used. As a control the pLKO.1-puro base lentiviral vector was transduced into stMSCs (stMSC vect The spontaneous transformation of the stMSC cell line in vitro produced a mutation in the p53 gene leading to altered expression (17) . To control for changes in oncogene expression in the cell line that could affect interpretation of the role of Shh, MSCs were isolated and cultured using the IRG mouse model expressing RFP under the chicken ␤-actin promoter (wtMSC) (8) . Freshly isolated and culture expanded MSCs maintained at low passage number do not exhibit malignant properties. These cells were then transfected to overexpress Shh at levels comparable to the stMSC vect cell line so any morphological changes or tumor development observed could be attributed to variation in the level of MSC-derived Shh (Fig 2A). Figure 2A shows that there was a significant increase in Shh protein expression in the wtMSC Shh and stMSC vect cells. In the presence of Shh and activation of Smoothened, Gli2 and Gli3 processing to the repressor form is blocked (7, 23, 29) . Consistent with activation of Shh signaling in the wtMSC Shh and stMSC vect cells, we observed a significant increase in the full-length Gli2 protein and a decrease in the repressor fragment by immunoblot (Fig. 2A) .
The role of autocrine Hh signaling within each MSC cell line was also examined by qRT-PCR using primers specific for Shh, Ptch, Gli 1, and Hhip. With activation of the Hh signaling pathway the transcription of these components is also elevated (21, 28). Relative to the wtMSC, the gene expression of Shh, Gli1, Ptch, and Hhip were significantly increased in the wtMSC Shh and stMSC vect cell lines while the stMSC ShhKO cell line displayed no apparent Shh expression or pathway activation based on transcript levels. The expression of Ptch was increased in both the wtMSC Shh and stMSC vect cell lines, with a 50-fold increase in gene transcript levels observed in the wtMSC Shh and a two-to threefold increase in the stMSC vect cells (Fig. 2B ). The autocrine activation of Hh signaling within the MSC cell lines and the differential expression of the Hh pathway components suggested that the Hh pathway may mediate the transition of MSCs from a benign to malignant cell type. One way in which this could occur is through the induction of cell proliferation. Proteins involved the regulation of the cell cycle are among the targets of the transcription factor Gli1 (34). We observed a significant increase in cell cycle genes cyclin B1 and cyclin D1 in both the wtMSC Shh and stMSC vect cells compared with wtMSC and stMSC ShhKO cells (Fig. 2C ). In addition, the percentage of the cell population in G 0 /G 1 , S, and G 2 /M was determined by flow cytometry in each cell line. The profile for the wtMSC Shh and stMSC vect cell lines was very similar, showing an increase in the percentage of cells in S phase compared with wtMSCs, while knockdown of Shh gene expression in the stMSC ShhKO cell line was able to revert levels of proliferation in the population back to wtMSC levels (Fig. 2,  D and E) . These data suggest that the Shh signaling pathway may be a key regulator of MSC phenotype through the induction of autocrine signaling and resultant increases in cell proliferation.
To verify that the knockdown of Shh in stMSCs did not alter the differentiation of the cells, an expression pattern for the classical CD markers (CD29, CD106, CD105, CD44, and CD73) and Sca-1 using flow cytometry was performed using cultured wtMSC (Fig. 3A) , wtMSC Shh (Fig. 3B ), stMSC vect ( Fig. 3C) , and stMSC ShhKO (Fig. 3D ) cells. Additionally, all cell lines were negative for the hematopoietic markers CD45 and CD11b (Fig. 3) . Collectively, these data suggest that knockdown of the Shh protein in stMSCs did not change the differentiation of these cells.
MSC-induced tumor growth was mediated by Hh signaling in GKO mice. The GKO mouse model was ideal to study the action of MSC-derived Shh on the epithelium within a chronically inflamed stomach. wtMSC, wtMSC posttransplantation with either wtMSC Shh or stMSC vect cells, histological evaluation revealed that the GKO mice developed gastric tumors with highly dysplastic gastric glands and gastric lesions that were invasive into the submucosa (Fig. 4, F and  G) , compared with the normal stomachs of BL/6 mice transplanted with wtMSC Shh (Fig. 4B) or stMSC vect cells (Fig. 4C) . Although GKO mice transplanted with either wtMSC (Fig. 4E ) or stMSC ShhKO (Fig. 4H ) cells exhibited atrophic gastritis typically observed in this animal model (35, 38) , no dysplasia or neoplastic transformation was observed. Normal histology was observed in the stomachs of wtMSC (Fig. 4A) -and stMSC ShhKO (Fig. 4D) -transplanted BL/6 animals. Histological scores documented the development of atrophic gastritis in the GKO mice and were significantly greater in the transplanted GKO mice compared with transplanted BL/6 mice (Fig. 5A) (Fig. 5B) . By 60 days posttransplantation, the GKO stMSC vect -transplanted group exhibited aggressive tumor development while the GKO stMSC ShhKO -transplanted group still maintained gastric morphology consistent with the chronic inflammation that develops in this animal model (Fig. 6, A and B) . The neoplasms that developed were characterized by a whirling pattern of pleomorphic spindle shaped cells with large nuclei and high mitotic activity infiltrating into the muscular wall and into the mucosa consistent with a sarcoma phenotype. Figure 2 demonstrates the autocrine pro-proliferative effect of Hh signaling on MSCs. Therefore, to identify whether the tumors were derived from the engraftment of transplanted MSCs, female recipient BL/6 or GKO mice were gastric transplanted with MSCs derived from male mice and in situ hybridization for the Y chromosome was performed (Fig. 7, A-H) . In all groups of BL/6 mice, Y chromosome-positive MSCs engrafted within the muscularis mucosa (shown in the representative micrographs in Fig. 7, A and B) . In GKO mice transplanted with either wtMSC Shh or stMSC vect , Y chromosome-positive cells were localized within the muscularis mucosa 30 days posttransplantation (shown in the representative micrographs in Fig. 7, D and E) and within the tumor stroma 60 days posttransplantation (shown in the representative micrographs in Fig. 7, G and H) . It was obvious in both the BL/6 (Fig. 7C) and GKO (Fig. 7, F and I) mice that proliferating Ki67-positive cells were present within the epithelium and were negative for the Y chromosome. These data demonstrated that once engrafted within the mucosa, MSCs may have lost their proliferative capacity that was observed in vitro. Therefore, tumor development observed was like to not be induced by the engraftment of proliferating MSCs.
MSC-derived Shh promotes the proliferation of epithelial and mesenchymal CD44-positive cell populations.
In gastric biopsies obtained from GKO mice transplanted with stMSC vect cells, a consistent increase in epithelial cell proliferation overlapping with the isthmus region of gastric glands was observed at 30 days compared with other experimental groups (Fig. 8, A-I ). In the 30-day time course, an expansion in this same region was observed in GKO stomachs with transplantation of wtMSC Shh cells and was lost with transplantation of wtMSC and stMSC ShhKO cells. These findings suggest the MSC-derived Shh promotes proliferation, and this response is indicates that Shh from MSCs promotes epithelial proliferation (Fig. 8, A-I) .
CD44 has been identified as a marker of gastric cancer stem cells, and increased expression of CD44 in response to H. pylori infection is associated with gastric carcinoma (11, 15, 27) . Recently an expansion of CD44-positive undifferentiated cells has been reported in response to tamoxifen-induced parietal cell atrophy and Helicobacter infection (16) . Based on this, gastric sections from BL/6 and GKO mice were stained using antibodies against CD44 and Ki67 (Fig. 9, A-D) . There was an expansion of CD44-positive proliferating glands within the stomachs of GKO mice transplanted with either wtMSC Shh cells (Fig. 9 , C and D) compared with BL mice transplanted with wtMSC Shh cells (Fig. 9, A and B) . The expansion of proliferating CD44-positive cells within the GKO mouse stomachs was not observed in those animals transplanted with either wtMSC or stMSC ShhKO cells (data not shown). A number of variant isoforms of CD44 are expressed and can serve as a prognostic factor and unique biomarker of gastric cancer development (6) . CD44 and the expression of the variant isoforoms, in particular CD44v6, are closely related to Helicobacter infection and gastric cancer progression (6, 11, 15) . Therefore, stomach sections collected from GKO mice transplanted with either wtMSC Shh or stMSC vect cells were immunostained using an antibody against CD44v6 and Hh receptor Ptch 60 days posttransplantation. CD44v6 was in fact detected only in tumor bearing GKO wtMSC Shh or stMSC vect stomachs. CD44v6 staining cells clustered in gland-like structures within the epithelium and tumor stroma and were positive for Ptch (Fig. 9E) . Expression of Ptch was confirmed by extracting RNA from these morphologically distinct gland-like structures captured from within the tumor stroma using LCM (Fig. 9F) . The captured cells from three representative tumors expressed both CD44 and Ptch (Fig. 9G ). While these cells expressed epithelial cell marker keratin, expression of the mesenchymal marker ␣-smooth muscle actin was expressed at low levels, suggesting that the CD44 Ϯ Ptch Ϯ cells were captured from epithelial glands. Collectively, these data suggest that Hh signaling derived from MSCs may induce the proliferation of CD44-positive cells within the gastric epithelium and tumor stroma.
DISCUSSION
Although it is well documented that MSCs migrate to the site of gastric inflammation (9, 10, 14, 25) , the role of these cells in cancer development is largely unknown as is the effect they have on the gastric epithelium. What is known is that MSCs may contribute to an environment that is compatible with the development of gastric cancer by providing an immunosuppressive response to H. pylori infection (19) . Alternatively, MSCs are reported to serve as the source of cancer- associated fibroblasts (25) . Here we report two major findings: 1) Shh provides a proliferative stimulus for MSCs, and 2) MSC-derived Shh may provide a proliferative stimulus within the gastric epithelium associated with tumor development. Our studies demonstrate that Shh provides a proliferative stimulus for MSCs. The role of autocrine Hh signaling within MSCs was demonstrated by elevated Ptch, Hhip, Gli1, and Gli2 expression with the overexpression of Shh ligand observed in both wtMSC Shh and stMSC vect cells. The autocrine activation of Hh signaling within these MSC cell lines suggested that the Hh pathway is likely to mediate the transition of MSCs from a benign to malignant cell type. There is strong evidence that gastric cancer originates from transformed BMMSCs in human (4, 32) and mouse (14) , yet the mechanism of such an in vivo transformation is largely unclear. We proposed that one way in which this could occur is through the induction of cell proliferation. Proteins involved in cell cycle, such as cyclin D1, are among the targets of the transcription factor Gli1 (39) . Indeed, cell cycle analysis showed that wtMSC Shh and stMSC vect cell lines exhibited an increase in the percentage of cells in S phase compared with wtMSCs and stMSC ShhKO cells. In vitro studies show that TGF-␤, often secreted during chronic gastritis, may contribute to BM-MSC transformation (25) . In support of these findings we have observed that Shh pathway activity within BM-MSCs is downstream of the TGF-␤ signaling (9) . Therefore, Shh signaling may be a key regulator of MSC phenotype in response to chronic inflammation through the induction of autocrine signaling and resultant increases in cell proliferation (Fig. 10) .
MSC-derived Shh also provides a proliferative stimulus within the gastric epithelium that may be associated with tumor development, a response that is sustained by chronic inflammation. The active proliferation observed in MSCs overexpressing Shh was not maintained after their transplantation and engraftment within the stomach. Rather, Shh-expressing stMSC and wtMSC Shh cells promoted epithelial cell proliferation within the stomach in response to chronic inflammation. A significant expansion in CD44-positive proliferating cells was observed in response to chronic inflammation within the GKO stomach in the presence of Shh-expressing wtMSC Shh and stMSC vect cells. Further analysis of these CD44-positive cells revealed the strong expression of Hh receptor Ptch, thus providing evidence that these cells are Hh responsive. CD44 is a cell surface adhesion molecule expressed on a variety of cells including gastric epithelial cells. Recently, CD44 has been identified as a gastric cancer stem cell marker (15, 27) and our data may suggest a possible interaction between recruited MSCs and CD44-positive cells. In support of this notion, CD44-positive cells isolated from human gastric cancer cell lines promote malignancy and form differentiated gastric cancer in SCID mice (27) . Moreover, atrophy of the acid-secreting parietal cell also induces an expansion in a population of CD44-positive undifferentiated cells in the gastric isthmus where stem cells normally reside (16) . Indeed, the striking Here we demonstrate that MSCs may promote the proliferation of CD44-positive cells, a potential gastric epithelial stem cell population, via a mechanism that is dependent on Shh and inflammation (Fig. 10) .
To identify whether the tumors were derived from the engraftment of transplanted MSCs, female recipient BL/6 or GKO mice were gastric transplanted with MSCs derived from male mice and in situ hybridization for the Y chromosome was performed. It was obvious from our data that the proliferating cells were confined to the epithelium, while the Y chromosome positive cells were observed either within the muscularis mucosa or within the tumor stroma. Therefore, once engrafted within the mucosa, MSCs do not proliferate suggesting that tumor development was not induced by the engraftment and expansion of proliferating MSCs. 
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Fig . 9 . Expression of CD44 and Ki67 in stomachs collected from BL/6 and GKO recipient mice. Representative images of immunostaining using antibodies specific for CD44 (red) and Ki67 (green) using stomach sections collected from BL/6 recipient mice (A) transplanted with wtMSC Shh cells (higher magnification in B) and GKO recipient mice (C) transplanted with wtMSC Shh cells (higher magnification in D). Arrows show CD44-positive cells. E: immunostaining of CD44v6 (red) and Ptch (green) in GKO recipient mice transplanted with stMSC vect cells. F: paraffin-embedded sections collected from gland-like epithelium within the tumor stroma were stained and the ultraviolet cutting laser was used to first ablate the cells surrounding the region (before and after). An infrared laser was then used to capture the cells from surface pit, neck, and base epithelium (captured). G: gene expression of CD44, Ptch, cytokeratin 20 (keratin), and ␣-smooth muscle actin (␣-SMA) was analyzed by qRT-PCR using RNA collected by Laser Capture Microdissection from 3 representative tumors (T1, T2, and T3) in GKO recipient mice transplanted with stMSC vect cells.
The current study uses gastric serosal transplantation of stMSCs and wtMSCs to study the role of MSC-derived Shh on the gastric epithelial cell proliferation. The use of an animal model to examine the role of MSC-derived Shh allows for contextual examination of the role of Hh in vivo. Site delivery of the cells allows for a controlled setting to understand the direct role of the cells on gastric epithelial cell proliferation. In addition, transplantation of MSCs within the inflamed gastric mucosa accelerated cancer progression in a murine model that in vivo would occur over the course of 1 yr with chronic inflammation (35) . While our data may be the first indication of an interaction between MSCs expressing Shh and CD44-positive cells, an important limitation is that the role of endogenous MSCs in the development of gastric cancer was not addressed in this model. Bolus dosing of cells does not recapitulate the neoplastic process. An alternative approach may be to study this in vitro using a coculture system between MSCs and newly developed gastric organoids cultures (2, 20) .
In summary, to establish that MSC-derived Shh acts as a proproliferative stimulus on the gastric epithelium, we generated several BM-MSC cell lines expressing variable levels of Shh ligand. Both the wtBM-MSCs and the stMSCs with low levels of Shh expression failed to induce epithelial proliferation and tumor development. In contrast, the MSC cell lines expressing high Shh ligand expression induced proliferation of CD44-positive epithelial cells and neoplastic changes within the epithelium. Therefore, we conclude that MSCderived Shh within the environment of the inflamed gastric mucosa may be sufficient to promote tumor development by inducing the proliferation of CD44-positive cells. CD44 has been identified as a putative gastric epithelial stem cell marker (16) . In addition, CD44 is identified as a gastric cancer stem cell marker that labels an epithelial cell population responsive to H. pylori (15, 27) . 
